Cannabis Sativa Inc (OTCMKTS:CBDS) showing of 0.00% and closed at $5.89, after gaining total volume of 49,597.00 million shares. Its earnings per share (EPS) is -$0.16 and its beta value stands at 18.81 points and has total market capitalization of $108.82 million and a total of 18.47 million outstanding shares.
Cannabis Sativa, Inc., through its subsidiaries, develops, manufactures, and sells herbal based skin care products in the United States and internationally. It offers herbal based line of products, including Go Deep, a deep penetrating healing salve that reduces pain and inflammation when massaged into muscles, ligaments, tendons, and joints; Go Deep EXTRA, a deep penetrating pain relief ointment for use in mitigating migraine and sinus headaches; Face Garden, an antioxidant and moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also engages in the research, development, and licensing of natural cannabis products comprising cannabis formulations, edibles, topicals, strains, recipes, and delivery systems. It markets and sells its products through sales professionals, as well as through retailers and distributors. Cannabis Sativa, Inc. is based in Mesquite, Nevada.
Earth Science Tech Inc (OTCMKTS:ETST) reported the plunge of -14.57% and closed at $1.70, with the total traded volume of 46,689.00 shares. During last trade its minimum price was $1.70 and it gained its highest price of $1.99 and has a total of -0.05 million outstanding shares.
On March 14, 2017 Earth Science Tech, Inc. (ETST), an innovative biotech company focused on cannabis (industrial hemp), cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices is proud to announce its subsidiaries Cannabis Therapeutic, Inc. and Earth Science Pharmaceutical, Inc. the nomination of Kim Foster-Cunningham to the post of Project Manager for the MSN-2 medical device project; and Denis Babin of SDB Import/Export, Inc. as international marketing consultant for Cannabis Therapeutics and Earth Science Pharmaceutical products.
Ms. Foster-Cunningham’s immediate focus is preparatory phase of the pre-market clinical trial of the MSN-2 medical device. The MSN-2 device is a revolutionary medical instrument for the detection and diagnosis of Chlamydia and Gonorrhea, from previous announcement, (ETST Announces 60-Patient Clinical Prelaunch Study for its MSN-2 Medical Device for the Diagnosis of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé as New CEO & CSO, and Nickolas Tabraue as President.)
Ms. Foster-Cunningham, whom holds a degree in sales and marketing, is recognized for her expertise in business networking and her solid business expertise. She is a sought-after speaker throughout the USA and Canada, delivering conferences on her proactive approach to general health and self-care. Passionate about individual sports, she is a half marathon runner and a triathlete. Always enthusiastic about transmitting her passion for health and business development, this project is “her new baby”.
CANNAGROW HLDGS IN COM USD0.001 (OTCMKTS:CGRW) decreased -2.08% closed at $1.41 and traded with total volume of 62,038.00 shares, while the average trading remained 183,942.00 shares. During last trade its minimum price was $1.40 and it gained the highest price of $1.48. Its market capitalization was $146.99 million.
CANNAGROW HLDGS IN COM USD0.001 (CGRW) on March 15, 2017 announced Category One Botanicals, LLC, the Licensed Grower, has received the lab analysis on the first Winer Test Run in the Ranger Series 2000 Climate Controlled Greenhouse.
Dr. John P. Janovec, COO stated, “Our first Winter Test Run in the IGC Ranger Series 2000 Greenhouses, http://www.igcusa.com/, has been a complete success and clearly demonstrates that our Ranger Greenhouses can be utilized for year-round production. All four (4) of the production strains tested between 18% and 22% for THC with all four (4) passing the ‘Microbial’ test, but the mold, yeast, and other microorganisms tested for were absent from the samples.”
Rod Clawson, Managing Member of Category One Botanicals, added, “The Ranger Series 2000 Climate Controlled Seasonal Greenhouses are no longer ‘Seasonal’ and have proven themselves to support a year-round growing environment. With three (3) of the 2,880 sq. ft. Rangers already on line and three (3) more currently under construction, future Winter Seasons will prove to be just as productive as standard Spring and Summer Growing Seasons. The selection of these particular structures by the CannaGrow Planning Team once again proves their expertise in all areas of the Cannabis Industry.”
Shareholders and interested parties are encouraged to visit the CannaGrow Holdings Blog for more information and updates from Colorado Buffalo Ranch Facility I at (http://www.cannagrowholdings.com).
CannaGrow Holdings, Inc., the Liaison and Representative for NuGro Industries, will continue in its capacity of providing oversight as the Facilities Manager, working with the State/County Agencies and Category One Botanicals, LLC, the Licensed Grower for the facilities. The completion of this project will now provide the company the basis to begin generating revenues from Licensed Growers subleasing the Turnkey facilities being built to the specifications of CannaGrow COO, Dr. John P. Janovec, and Consultant, Jason Wells.